NCT00834249View on ClinicalTrials.gov

Venlafaxine 25 mg Tablets Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions
Healthy
Interventions
DRUG

Venlafaxine 25 mg Tablets

1 x 25 mg, single-dose fasting

DRUG

Effexor® 25 mg Tablets

1 x 25 mg, single-dose fasting

Trial Locations (2)

H3X 2H9

Anapharm Inc., Montreal

GIV2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00834249 - Venlafaxine 25 mg Tablets Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter